<DOC>
	<DOCNO>NCT01198353</DOCNO>
	<brief_summary>This study design aim evaluate clinical effect overlap switch ziprasidone well efficacy safe metabolic profile ziprasidone .</brief_summary>
	<brief_title>Effectiveness Ziprasidone Patients With Schizophrenia</brief_title>
	<detailed_description>Patients schizophrenia schizoaffective disorder recruit 12-week , multicenter , non-comparative , open-label trial . Prior antipsychotic allow maintain 4 week titration ziprasidone . Efficacy primarily measure use 18-item Brief Psychotic Rating Scale ( BPRS ) baseline , 4 week , 8 week , 12 week . Efficacy secondarily measure Clinical Global Impression - Severity ( CGI-S ) scale Global Assessment Functioning ( GAF ) scale visit . Regarding metabolic effect switch ziprasidone , weight , body mass index ( BMI ) , waist-to-hip ratio ( WHR ) , lipid profile—including triglyceride ( TG ) , high-density lipoprotein ( HDL ) , low-density lipoprotein ( LDL ) , total cholesterol levels—were measure follow-up visit .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Male female age 1855 year treat risperidone , olanzapine , amisulpride , quetiapine typical antipsychotic . Both outpatient meet Diagnostic Statistical Manual Mental Disorders ( DSMIV ) criteria schizophrenia schizoaffective disorder . Their primary psychiatric clinician determine would benefit change medication , either suboptimal efficacy side effect . Those treated medication prolong QTc interval . Those axis I DSMIV diagnosis . Those history substance abuse dependence within 1 month . Those clinically significant abnormal laboratory value abnormal baseline laboratory finding consider psychiatrist indicative condition might affect study result . Those past history hypersensitivity intolerance ziprasidone . Those history clozapine use within 1 month . Those participated clinical trial within 1 month enter study entry . Those used depot antipsychotic within one cycle enter study . Those pregnant breast feeding . Those immediate risk harm self others history suicide attempt year screening preclude inclusion study . The patient unable/unlikely comprehend/follow protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective Disorder</keyword>
	<keyword>Ziprasidone</keyword>
	<keyword>Switch</keyword>
	<keyword>Metabolic syndrome</keyword>
</DOC>